Impact of 5-Fluorouracil (5-FU) on Cancer Cells From Liver Metastases of Colon Cancer
Withdrawn
- Conditions
- Cancer of ColonMetastasis to Liver
- Interventions
- Procedure: Scheduled and planned surgery
- First Posted Date
- 2020-02-18
- Last Posted Date
- 2024-02-14
- Lead Sponsor
- Centre Leon Berard
- Registration Number
- NCT04274790
- Locations
- 🇫🇷
Centre Léon Bérard, Lyon, France
Observational Study Evaluating the Psychic Impact of the Diagnostic Announcement and Care for Children Treated for Cancer
Terminated
- Conditions
- Pediatric Cancer
- First Posted Date
- 2020-01-28
- Last Posted Date
- 2021-10-13
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 5
- Registration Number
- NCT04244955
- Locations
- 🇫🇷
Centre Léon Bérard, Lyon, France
MEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma
Phase 1
Active, not recruiting
- Conditions
- Sarcoma,Soft Tissue
- Interventions
- First Posted Date
- 2020-01-03
- Last Posted Date
- 2024-07-08
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 320
- Registration Number
- NCT04216953
- Locations
- 🇫🇷
Hôpital de la Timone, Marseille, France
🇫🇷Institut Gustave Roussy, Villejuif, France
🇫🇷Institut Curie, Paris, France
Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure
Phase 2
Completed
- Conditions
- Gastro Intestinal Stromal Tumour
- Interventions
- First Posted Date
- 2019-12-10
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 77
- Registration Number
- NCT04193553
- Locations
- 🇫🇷
Institut de Cancérologie de Lorraine Alexis Vautrin, Vandœuvre-lès-Nancy, Meurthe-et-Moselle, France
🇫🇷Hopital de La Timone, Marseille, Bouches Du Rhône, France
🇫🇷Centre Antoine LACASSAGNE, Nice, Alpes-Maritimes, France
A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/characteristics in Advanced / Metastatic Tumors.
Phase 2
Recruiting
- Conditions
- Malignant Solid Tumor
- Interventions
- First Posted Date
- 2019-10-04
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 455
- Registration Number
- NCT04116541
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, France
🇫🇷Centre Léon Bérard, Lyon, France
🇫🇷Institut Paoli Calmettes, Marseille, France
Evaluating AGuIX® Nanoparticles in Combination With Stereotactic Radiation for Brain Metastases
- First Posted Date
- 2019-09-18
- Last Posted Date
- 2021-06-08
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 1
- Registration Number
- NCT04094077
- Locations
- 🇫🇷
Centre Léon Bérard, Lyon, France
🇫🇷Centre Antoine Lacassagne, Nice, France
Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase
Phase 2
Active, not recruiting
- Conditions
- BCR-ABL Positive Chronic Myelogenous LeukemiaPhiladelphia Chromosome Positive CML
- Interventions
- First Posted Date
- 2019-08-28
- Last Posted Date
- 2024-04-08
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 170
- Registration Number
- NCT04070443
- Locations
- 🇫🇷
CHU Limoges - Hôpital Dupuytren, Limoges, France
🇫🇷Centre Hospitalier Annecy-Genevois, Annecy, France
🇫🇷Iuct Toulouse - Oncopole, Toulouse, France
Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas
Not Applicable
Recruiting
- Conditions
- LeiomyosarcomaBone SarcomaOsteosarcomaChondrosarcomaUndifferentiated Pleomorphic SarcomaEwing SarcomaAngiosarcoma
- Interventions
- Drug: Treatment by Placebo
- First Posted Date
- 2019-08-13
- Last Posted Date
- 2023-08-08
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 168
- Registration Number
- NCT04055220
- Locations
- 🇫🇷
Hôpital Jean Minjoz, Besançon, France
🇫🇷Institut Bergonié, Bordeaux, France
🇫🇷Centre Oscar Lambret, Lille, France
An Individualized Physical Activity Program in Patients Over 65 Years With Hematologic Malignancies
Not Applicable
Completed
- Conditions
- ExerciseQuality of LifeLeukemia, Myeloid, AcuteFatigueAgedAged, 80 and OverLymphoma, Non-Hodgkin
- Interventions
- Other: Individualized physical activity program
- First Posted Date
- 2019-08-09
- Last Posted Date
- 2023-08-30
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 43
- Registration Number
- NCT04052126
- Locations
- 🇫🇷
Centre Léon Bérard, Lyon, France
PATAKESS Protocol : Clinical and Biological Analysis of Exocrine Pancreatic Tumors
Recruiting
- Conditions
- Exocrine Pancreatic Cancer
- First Posted Date
- 2019-07-09
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 300
- Registration Number
- NCT04011982
- Locations
- 🇫🇷
Centre Léon Bérard, Lyon, France
© Copyright 2025. All Rights Reserved by MedPath